The rising prevalence in GLP-1 drugs for diabetes has led to a debate about delivery methods : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were exclusively available in tablet https://amiekarf322020.aioblogs.com/93654037/glp-1-transdermal-delivery-systems-vs-pills-which-best-for-the-patient